Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.
North Shore University Hospital’s cardiology team became the first to complete a procedure using the novel OmniaSecure ...
The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm) lead, which ...
Early defibrillation plays a key role in improving survival in patients with out-of-hospital cardiac arrests due to ventricular fibrillation (ventricular-fibrillation cardiac arrests), and the use of ...
If you haven’t had to perform CPR for a patient who was being shocked by an automated implantable cardioverter defibrillator (AICD), give it time. Approximately 800,000 people in the United States ...
Researchers used an electrophysiological computer model of the heart's electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios. They ...
OBJECTIVETo determine the use of epinephrine (adrenaline) before defibrillation for treatment of in-hospital cardiac arrest due to a ventricular arrhythmia and examine its association with patient ...
Please provide your email address to receive an email when new articles are posted on . A novel defibrillation lead beat safety and efficacy goals in a pivotal trial. The goal of physicians is for the ...
Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED; rapid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback